An Investigation of Effectiveness and Safety of Varenicline Tartrate in Helping People Quit Smoking
NCT00371813 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 334
Last updated 2015-04-22
Summary
To investigate safety and efficacy of varenicline tartrate in helping people quit smoking
Conditions
- Smoking Cessation
Interventions
- DRUG
-
Varenicline tartrate
- DRUG
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Pfizer CT.gov Call Center · Pfizer
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-09-30
- Completion
- 2007-06-30
Countries
- China
- Singapore
- Thailand
Study Locations
More Related Trials
-
A Study to Evaluate the Safety and Efficacy of Three Doses of a Controlled Release Formulation of Varenicline for Smoking Cessation
NCT00741884 ·Status: WITHDRAWN ·Phase: PHASE2
-
A 52-Week Placebo-Controlled Study Evaluating the Safety of Varenicline
NCT00143299 ·Status: COMPLETED ·Phase: PHASE3
-
Smoking Cessation Study In Healthy Adolescent Smokers
NCT01312909 ·Status: COMPLETED ·Phase: PHASE4
-
A Multi-National Study To Assess How Effective And Safe The Smoking Cessation Medicine Varenicline Is In Smokers Who Have Already Tried Varenicline In The Past As A Prescription Medicine From Their Usual Healthcare Provider
NCT01244061 ·Status: COMPLETED ·Phase: PHASE4
-
Randomized Study Comparing the Efficacy and Safety of Varenicline Tartrate to Placebo in Smoking Cessation When Subjects Are Allowed to Set Their Own Quit Date
NCT00691483 ·Status: COMPLETED ·Phase: PHASE4
-
Varenicline-Aided Cigarette Reduction in Smokers Not Ready to Quit
NCT01308736 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Varenicline in Smokers With Cardiovascular Disease Who Wish to Quit Smoking
NCT00282984 ·Status: COMPLETED ·Phase: PHASE3
-
A Twelve-Week Study of Varenicline for Safety and Efficacy in Comparison With Placebo and Zyban for Smoking Cessation
NCT00141206 ·Status: COMPLETED ·Phase: PHASE3
-
Phase 1 Clinical Trial of Varenicline in Chinese Healthy Smoking Volunteers
NCT00452894 ·Status: COMPLETED ·Phase: PHASE1
-
Varenicline for Long-term Nicotine Replacement Therapy (NRT) Users
NCT00977249 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Long-term Varenicline Treatment for Smoking Cessation
NCT00828113 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Varencline Effects on Cigarette Smoking Reward and Craving During a Model of Brief Quit Attempt
NCT00571805 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Varenicline for Adolescent Smoking Cessation
NCT01509547 ·Status: COMPLETED ·Phase: PHASE3
-
Multiple Dose, Dose Escalation Study of Varenicline Controlled Release Formulation in Adult Smokers
NCT00527150 ·Status: COMPLETED ·Phase: PHASE1
-
Varenicline Light Smoking Pilot
NCT04089982 ·Status: COMPLETED ·Phase: PHASE4
-
A Twelve-Week Study of Varenicline for Safety and Efficacy in Comparison With Placebo and Zyban for Smoking Cessation
NCT00143364 ·Status: COMPLETED ·Phase: PHASE3
-
12 Week Evaluation of the Safety and Efficacy of 3 Doses of CP-526,555 and Placebo for Smoking Cessation
NCT00139750 ·Status: COMPLETED ·Phase: PHASE2
-
Varenicline (Chantix) Treatment for Waterpipe Smoking Cessation
NCT02575183 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Varenicline Safety, Tolerability, Pharmacokinetics and Pro-Cognitive Effects in Healthy Elderly Non-Smoking Subjects
NCT00694044 ·Status: COMPLETED ·Phase: PHASE1
-
A Seven-Week Dose-Ranging Study of CP-526,555 Compared With Placebo and Zyban for Smoking Cessation
NCT00150241 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Varenicline on Smoking Reminders
NCT01524627 ·Status: COMPLETED ·Phase: PHASE2
-
Effectiveness of Varenicline: Testing Individual Differences
NCT01228175 ·Status: COMPLETED ·Phase: PHASE4
-
Varenicline Tartrate With Telephone-Based Counseling and/or Internet-Based Counseling in Helping Adults Stop Smoking
NCT00301145 ·Status: COMPLETED ·Phase: NA
-
Safety And Efficacy Of 12 Weeks Of Varenicline For Smoking Cessation In Smokers With Depression
NCT01078298 ·Status: COMPLETED ·Phase: PHASE4
-
Varenicline OTC Trial on Efficacy and Safety
NCT03557294 ·Status: COMPLETED ·Phase: PHASE4